Request Demo
Last update 08 May 2025
Desvenlafaxine Benzoate
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Desvela, 데스베라서방정 |
Target |
Action inhibitors |
Mechanism MAO inhibitors(Monoamine oxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (09 Apr 2025), |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Desvenlafaxine BenzoateTCTR20240322003
A Multiple-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiq) in Healthy Thai Volunteers under Fasting Conditions
TCTR20240326004
A Single-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product in Healthy Thai Volunteers under Fasting and Fed Conditions
TCTR20210326006
A double-blind randomized placebo-controlled study of Desvenlafaxine for managing vasomotor symptoms in breast cancer survivors
100 Clinical Results associated with Desvenlafaxine Benzoate
Login to view more data
100 Translational Medicine associated with Desvenlafaxine Benzoate
Login to view more data
100 Patents (Medical) associated with Desvenlafaxine Benzoate
Login to view more data
100 Deals associated with Desvenlafaxine Benzoate
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Depressive Disorder, Major | South Korea | 09 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free